ARTICLE | Distillery Therapeutics
Cardiovascular
February 22, 2017 7:07 PM UTC
Mouse studies suggest dual FPR1/FPRL1 agonists could help treat MI. In primary rat and mouse cardiomyocyte-based models of ischemia/reperfusion, a dual FPR1/FPRL1 agonist tool compound decreased level...
BCIQ Company Profiles